市场调查报告书
商品编码
1567801
北美中胚层疗法市场预测至 2030 年 - 区域分析 - 按产品类型、适应症和最终用户North America Mesotherapy Market Forecast to 2030 - Regional Analysis - by Product Type, Indication, and End Users |
2022年北美中胚层疗法市场估值为1.3434亿美元,预计2030年将达到2.7762亿美元;预计2022年至2030年复合年增长率为9.5%。
联合疗法日益普及的推广了北美中胚层疗法市场
对个人化治疗、全面结果和微创选择的要求导致了对联合疗法的高度偏好。这些疗法涉及使用多种治疗方式或产品,以达到比单独使用单一疗法更好的效果。根据 DermaNetwork.org 报导,中胚层疗法可以与抽脂、肉毒桿菌、purtox、微晶换肤术和 Fraxel 治疗相结合。例如,美塑疗法(美塑疗法和肉毒桿菌的组合)透过将高稀释度的美塑疗法溶液和肉毒桿菌毒素注射到皮肤中,广泛用于脸部年轻化。同样,中胚层疗法和富血小板血浆 (PRP) 疗法相结合有助于刺激胶原蛋白和弹性蛋白的产生,这对修復皮肤很重要。 PRP 利用自然癒合过程,比传统的美塑疗法提供更持久的效果(长达 6 个月)。正在进行各种研究,以了解中胚层疗法和 PRP 组合方法在治疗不同疾病方面的益处。 PRP 和美塑疗法的组合目前用于治疗脱髮。例如,先进的 Nano Meso 解决方案结合了中胚层疗法和 PRP,用于治疗脱髮和稀疏,然后刺激男性和女性的头髮生长。该解决方案预计对患有雄性秃和年龄相关性脱髮的人更有效。因此,联合疗法的趋势预计将有利于中胚层疗法市场的表现,因为它可以带来高品质的皮肤效果、降低疼痛和缩短恢復时间等好处。
北美美塑疗法市场概况
北美中胚层疗法市场分为美国、加拿大和墨西哥;到2022 年,美国将占据最大的市场份额。成长机会。在美国,由于对更有效、微创美容手术的持续需求,中胚层疗法已被认为是一种出色的美容治疗选择。它在疼痛管理、运动医学和风湿病学等应用中也越来越受到关注。随着该国老年人口的不断增长,对中胚层疗法的需求可能会进一步增加,特别是治疗疼痛和脸部老化迹象。根据美国皮肤病学会的数据,近 8,000 万美国人患有雄性秃(脱髮),而痤疮每年影响多达 5,000 万美国人。因此,美国人口中皮肤病的高盛行率有可能推动对中胚层疗法产品和服务的需求。儘管美国食品药物管理局 (FDA) 尚未批准任何美塑疗法程序,但已批准了几种用于美塑疗法的成分。因此,它们被认为是标籤外批准的成分。而且,美国整形外科医师协会(ASPS)不建议溶脂注射用于中胚层疗法。因此,监管的不确定性导緻美国美塑疗法市场出现违规行为。
北美中胚层疗法市场收入及 2030 年预测(百万美元)
北美中胚层疗法市场区隔
北美中胚层疗法市场按产品类型、适应症、最终用户和国家分类。
根据产品类型,北美美塑疗法市场分为美塑疗法解决方案套件、美塑疗法设备、美塑疗法填充剂套件、美塑疗法化学换肤和抗衰老面膜。 2022 年,中胚层疗法解决方案套件细分市场占据最大市场份额。
从适应症来看,北美美塑疗法市场分为抗衰老和皱纹治疗、脸部年轻化、减肥、脱髮、妊娠纹以及痤疮和疤痕治疗。 2022 年,抗衰老和皱纹治疗设备领域占据北美美塑疗法市场的最大份额。
根据最终用户,北美美塑疗法市场分为皮肤科诊所、美容诊所、医院等。 2022 年,皮肤科诊所占据北美美塑疗法市场的最大份额。
根据国家/地区,北美美塑疗法市场分为美国、加拿大和墨西哥。 2022年,美国在北美美塑疗法市场份额中占据主导地位。
Koru Pharma Co Ltd、Institute BCN Esthetics SL、Mesoskinline ApS、Colgate Palmolive Co、Mesoestetic E-Commerce SL、Galderma SA、Derm Beauty International Sdn Bhd 和 Ostar Beauty Sci-Tech Co Ltd 是该领域运营的一些领先公司。中胚层疗法市场。
The North America mesotherapy market was valued at US$ 134.34 million in 2022 and is expected to reach US$ 277.62 million by 2030; it is estimated to register a CAGR of 9.5% from 2022 to 2030.
Growing Adoption of Combination Therapies Fuels North America Mesotherapy Market
The requirement for personalized treatments, comprehensive results, and minimally invasive options results in a high preference for combination therapies. These therapies involve the use of multiple treatment modalities or products to achieve better results than a single therapy alone. According to DermaNetwork.org, mesotherapy can be combined with liposuction, botox, purtox, microdermabrasion, and Fraxel treatments. For instance, mesobotox therapy (a combination of mesotherapy and botox) is widely used for face rejuvenation by injecting a mesotherapy solution and botulinum toxin in high dilution into the skin. Similarly, combining mesotherapy and platelet-rich plasma (PRP) therapy helps stimulate the production of collagen and elastin proteins that are important for repairing skin. The PRP utilizes the natural healing process and provides longer-lasting results (up to 6 months) than a conventional mesotherapy procedure. Various research studies are being carried out to understand the benefits of the mesotherapy and PRP combinational approach in treating different medical conditions. The combination of PRP and mesotherapy is currently used to treat hair loss. For instance, the advanced Nano Meso solution, a combination of mesotherapy and PRP, is offered to treat hair loss and thinning, followed by stimulating hair growth in men and women. The solution is expected to be more effective for people suffering from androgenetic alopecia and age-related hair loss. Thus, the trend for combination therapies is expected to benefit the mesotherapy market performance by unlocking benefits such as high-quality results for skin, with lower pain and recovery time.
North America Mesotherapy Market Overview
The North America mesotherapy market is segmented into the US, Canada, and Mexico; the US held the largest share of the market in 2022. The countries are expected to have vital growth opportunities due to the increasing numbers of clinics and hospitals providing mesotherapy services, and an upsurge in government support to enhance the mesotherapy approach for cosmetic applications. In the US, mesotherapy has gained acceptance as an excellent cosmetic treatment option owing to the continued demand for more effective, minimally invasive cosmetic procedures. It is also gaining more attention in applications such as pain management, sports medicine, and rheumatology. The demand for mesotherapy procedures is further likely to rise with the growing geriatric population in the country, especially to treat pain and facial aging signs. According to the American Academy of Dermatology, nearly 80 million Americans suffer from androgenetic alopecia (hair loss), while acne affects up to 50 million Americans every year. Thus, the high prevalence of skin conditions in the US population has the potential to drive the demand for mesotherapy products and services. Although the US Food and Drug Administration (FDA) has not approved any mesotherapy procedure, it has approved several ingredients used for mesotherapy. Hence, they are considered off-label approved ingredients. Moreover, the American Society for Plastic Surgeons (ASPS) does not recommend lipolysis injection for mesotherapy. Thus, regulatory uncertainties result in irregularities in the mesotherapy market in the US.
North America Mesotherapy Market Revenue and Forecast to 2030 (US$ Million)
North America Mesotherapy Market Segmentation
The North America mesotherapy market is categorized into product type, indication, end users, and country.
Based on product type, the North America mesotherapy market is segmented into mesotherapy solution kits, mesotherapy devices, mesotherapy fillers kits, mesotherapy chemical peels, and anti-ageing masks. The mesotherapy solution kits segment held the largest market share in 2022.
In terms of indication, the North America mesotherapy market is segmented into anti-ageing & wrinkle treatment, facial rejuvenation, fat loss, hair loss, stretch marks, and acne & scar treatment. The anti-ageing & wrinkle treatment devices segment held the largest share of North America mesotherapy market in 2022.
Based on end users, the North America mesotherapy market is categorized into dermatology clinics, cosmetic clinics, hospitals, and others. The dermatology clinics segment held the largest share of North America mesotherapy market in 2022.
Based on country, the North America mesotherapy market is categorized into the US, Canada, and Mexico. The US dominated the North America mesotherapy market share in 2022.
Koru Pharma Co Ltd, Institute BCN Esthetics SL, Mesoskinline ApS, Colgate Palmolive Co, Mesoestetic E-Commerce SL, Galderma SA, Derm Beauty International Sdn Bhd, and Ostar Beauty Sci-Tech Co Ltd are the some of the leading companies operating in the North America mesotherapy market.